Detailed description page of PRRDB2.0
This page displays user query in tabular form. |
PRRID_0913 details |
Primary information | |
---|---|
PRRID | PRRID_0913 |
Ligand Name | Imidazoquinoline |
Source | A tricyclic aromatic heterocycle formed by fusion of an imidazole ring with the pyridine ring |
Sequence of ligand | CC1=C(NC(=C(C1=C2C=CC(=C(C2=O)OC)OC)N)C3=NC4=C(C=C3)C(=O)C(=C5C4=NC(N5)(C)C)OC)C(=O)O |
Length | NA |
Type | Pattern-associated molecular patterns (PAMPs) |
Occurence | Synthetic |
Role of Ligand | Imidazoquinolines are being actively being pursued for therapeutic use anti-viral and anti- allergic |
Name of receptor | Toll-like receptor 7 (TLR7) |
Type of receptor | Toll-like receptor (TLR) |
Source | NA |
Localization | NA |
Domain | NA |
Sequence of Receptor | NA |
Swiss prot ID | NA |
Length Of Receptor | NA |
Function | TLR7-mediated activation of these cells resulted in the induction of the pro-inflammatory cytokines IFN-α, IFN-β, TNF-α, and IL-13 |
Assay used | NA |
PMID | 21955443 |
Year of Publication | 2011 |
Pubchem assay | NA |
Primary information | |
---|---|
PRRID | PRRID_0913 |
Ligand Name | Imidazoquinoline |
Source | A tricyclic aromatic heterocycle formed by fusion of an imidazole ring with the pyridine ring |
Sequence of ligand | CC1=C(NC(=C(C1=C2C=CC(=C(C2=O)OC)OC)N)C3=NC4=C(C=C3)C(=O)C(=C5C4=NC(N5)(C)C)OC)C(=O)O |
Length | NA |
Type | Pattern-associated molecular patterns (PAMPs) |
Occurence | Synthetic |
Role of Ligand | Imidazoquinolines are being actively being pursued for therapeutic use anti-viral and anti- allergic |
Name of receptor | Toll-like receptor 7 (TLR7) |
Type of receptor | Toll-like receptor (TLR) |
Source | NA |
Localization | NA |
Domain | NA |
Sequence of Receptor | NA |
Swiss prot ID | NA |
Length Of Receptor | NA |
Function | TLR7-mediated activation of these cells resulted in the induction of the pro-inflammatory cytokines IFN-α, IFN-β, TNF-α, and IL-13 |
Assay used | NA |
PMID | 21955443 |
Year of Publication | 2011 |
Pubchem assay | NA |